Billing service transition
An update for our customers
Lantheus is bringing all billing for Lantheus-branded products in-house. Invoices will be issued by Progenics Pharmaceuticals Inc., a subsidiary of Lantheus. This change replaces the prior billing system used by Sofie Biosciences. It is designed to simplify operations, improve accuracy and support future growth while maintaining the high level of service you expect.
What this means for you
Faster resolution
Aligned billing processes result in fewer delays, greater accuracy and quicker turnaround on any questions or issues.
Centralized support
A single point of contact for billing, invoicing and payment inquiries.
Administrative impact
No change to contracts, pricing, commercial agreements, order fulfillment, credit approvals or unused dose credit procedures.
Continued support
Lantheus and Sofie teams remain available during the transition.
What happens next
To create a smooth transition for you and your team, we’ve outlined the next steps you’ll need to complete.
- Add Progenics Pharmaceuticals Inc. to your vendor master.
- Use the provided W-9 and banking information below.
- Begin using the new remittance instructions for ACH, wire or check payments.
Banking Information for Progenics Pharmaceuticals Inc.
(a subsidiary of Lantheus Medical Imaging, Inc.):
ACH Payments
Routing Number: 021000021
Account Number: 661509999
Account Name: Progenics Pharmaceuticals Inc.
Wire Transfers
Routing Number: 021000021
SWIFT Code: CHASUS33
Bank: JPMorgan Chase, New York, NY 10017
Account Number: 661509999
Account Name: Progenics Pharmaceuticals Inc.
USPS Check Delivery
Progenics Pharmaceuticals, Inc.
P.O. Box 735664
Dallas, TX 75373-5664
Overnight Courier Check Delivery
JPMorgan Chase (TX1-0029)
Attn: Progenics Pharmaceuticals, Inc. & 735664
14800 Frye Road, 2nd Floor
Fort Worth, TX 76155
- Pay remaining Sofie invoices using their original remit-to details.
- Only pay the entity listed on the invoice to avoid duplicate payments.
- Keep Sofie and Lantheus balances separate in AP systems.
- For Sofie invoice questions, contact billing@sofie.com.
- If your system requires it, issue updated purchase orders to Progenics Pharmaceuticals Inc.
- Notify your AP, procurement and finance teams of the changes and updated billing contacts.
How to Notify Lantheus
Steps
- Open a new email to CSPYL@lantheus.com
- Use the subject line: Billing Transition – [Your Company Name]
- Copy the template into the body of your email
- Fill in your company details
- Attach your new purchase order if required by your system
- Send the email
Template
Subject: Billing Transition – [Customer Company Name]
Body:
Dear Lantheus Billing Team,
We confirm completion of the required steps for the billing transition:
- Vendor Setup: Progenics Pharmaceuticals Inc. has been added to our vendor master
- Purchase Order: [Attached / Not required by our system]
- Banking Update: Our Accounts Payable team has updated payment instructions to Lantheus’ new remittance details
- Sofie Invoices: All open Sofie invoices will be paid directly to Sofie
Please confirm our transition is complete.
Thank you,
[Customer Contact Name]
[Title]
[Company]
Have questions or need support?
Our team is here to guide you through this change. Reach out to 1-800-964-0446 or CSPYL@lantheus.com Monday through Friday, 8am to 8pm EST. Please include “URGENT” in the subject line of your message or contact your account manager for urgent requests.
For more information, review our frequently asked questions.